# Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure

> **NCT01292486** · NA · COMPLETED · sponsor: **Terumo BCT** · enrollment: 32 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DEVICE:** Spectra Optia Apheresis System

## Key facts

- **NCT ID:** NCT01292486
- **Lead sponsor:** Terumo BCT
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01292486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01292486, "Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01292486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*